Funding for this research was provided by:
Shire ViroPharma Inc.
Shire Human Genetic Therapies Inc.
Article History
Accepted: 22 September 2020
First Online: 15 October 2020
Declarations
:
: This study was funded by Shire ViroPharma, Inc., a member of the Takeda group of companies.
: Ivy H. Song, Richard D. Finkelman, and Lan Lan are full-time employees of Shire, a member of the Takeda group of companies, and stockholders of Takeda.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This study was approved by the IntegReview Independent Review Board (dated 5 October 2017).
: Consent to participate was obtained from all individuals included in this study.
: Not applicable.
: Not applicable.
: Not applicable.
: Informed consent was obtained from all individual participants included in this study.
: All authors contributed to the study design and analysis, and critically reviewed the manuscript.